1. Home
  2. SMTI vs WHWK Comparison

SMTI vs WHWK Comparison

Compare SMTI & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$23.97

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$3.86

Market Cap

233.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTI
WHWK
Founded
1982
2007
Country
United States
United States
Employees
N/A
23
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.2M
233.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SMTI
WHWK
Price
$23.97
$3.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$34.00
$7.50
AVG Volume (30 Days)
59.5K
635.0K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$15,586,976.00
N/A
Revenue This Year
$17.31
N/A
Revenue Next Year
$12.48
N/A
P/E Ratio
$484.60
N/A
Revenue Growth
32.47
N/A
52 Week Low
$16.05
$1.57
52 Week High
$35.70
$5.50

Technical Indicators

Market Signals
Indicator
SMTI
WHWK
Relative Strength Index (RSI) 56.82 41.54
Support Level $20.47 $3.85
Resistance Level $26.48 $4.38
Average True Range (ATR) 1.44 0.39
MACD 0.08 -0.04
Stochastic Oscillator 67.05 14.16

Price Performance

Historical Comparison
SMTI
WHWK

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Share on Social Networks: